Global Implantable Drug Delivery Devices Market To Generate Revenue Of About USD 17.5 Billion By 2021

A new report has been released by Zion Market Research titled “Implantable Drug Delivery Devices Market (Drug Infusion Pumps, Drug Delivery Devices, Bio-Absorbable Stents, Coronary Drug Eluting Stents, Brachytherapy Seeds, Contraceptive Drug Delivery Implants and Others) for Oncology, Contraception, Cardiovascular, Ophthalmology, Inflammatory Conditions, Diabetes and Other End-users: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021.” The global implantable drug delivery devices market, as per the report, was capitalized at about USD 11.6 Billion in 2015 and is projected to make income of about USD 17.5 Billion by completion of 2021, developing at a CAGR of about 7.1% from 2016 to 2021.

Site-specific drug delivery is possible with the assistance of implantable drug delivery devices. This is of huge significance in oncology and cardiology. Implantable drug delivery devices assist in the continuous discharge of a therapeutic agent. They need smaller doses in comparison to its equivalents that consequently decrease the likelihood of side-effects from medications. Implantable drug delivery devices are utilized in several applications consisting of diabetes management, HIV/AIDS prevention, central nervous system (CNS) health, chronic pain management, contraception, cardiology, and oncology.

Browse the full "Implantable Drug Delivery Devices Market (Drug Infusion Pumps, Drug Delivery Devices, Bio-Absorbable Stents, Coronary Drug Eluting Stents, Brachytherapy Seeds, Contraceptive Drug Delivery Implants and Others) for Oncology, Contraception, Cardiovascular, Ophthalmology, Inflammatory Conditions, Diabetes and Other End-users: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021" report at https://www.zionmarketresearch.com/report/implantable-drug-delivery-devices-market

The growth of the global implantable drug delivery devices market is mostly propelled by the rising number of elderly people and incidence of target diseases like chronic diseases and diabetic retinopathy. Other key factor driving the implantable drug delivery devices market growth is increasing cases of unsolicited pregnancies. Nevertheless, stringent government policies enforced on this market and the high price of these devices are key factors that might hamper the market growth. However, the launch of new and more efficient implantable drug delivery devices is projected to unravel the new prospects for market in the coming period.

Based on products, he implantable drug delivery devices market is bifurcated into drug delivery devices, drug infusion pumps, coronary drug eluting stents, bio-absorbable stents, contraceptive drug delivery implants, brachytherapy seeds, and others. The largest share in the global implantable drug delivery devices market was grabbed by the implantable drugs infusion pumps. Further, it is anticipated to maintain its supremacy and be the rapidly developing segment in the years to come.  Another key segment in the market is contraceptive drug delivery device.

Based on end-users, the global implantable drug delivery devices market is categorized into diabetes, oncology, cardiovascular, birth control/contraception, inflammatory conditions, ophthalmology, and others. In terms of revenue, the cardiovascular end-user segment rules the market. The cardiovascular segment is projected to have a robust expansion in the years to come and is anticipated to the rapidly developing segment owing to the rising implementation of bio-absorbable stents.

Regionally, the global implantable drug delivery devices market is divided into Europe, North America, Latin America, the Middle East & Africa, and Asia-Pacific. Over the forecast period, North America is projected to stay at the top followed by Europe in 2015. Furthermore, Asia Pacific is also anticipated to grow at a noteworthy rate in the implantable drug delivery devices market in the near future. Additionally, Latin America is also projected to display modest growth in the market during the forecast period.

Few of the key players active in the implantable drug delivery devices market comprise Medtronic Inc, Bausch & Lomb Inc., Arrow International, Boston Scientific Corporation, Varian Medical Systems, Theragenics, Merck, Allergan Inc, Abbott laboratories, and Bayer Healthcare, amongst others.

This report segments the global implantable drug delivery devices market as follows:

Global Implantable Drug Delivery Devices Market: Product Segment Analysis

• Drug Infusion Pumps
• Drug Delivery Devices
• Bio-Absorbable Stents
• Coronary Drug Eluting Stents
• Brachytherapy Seeds
• Contraceptive Drug Delivery Implants
• Others

Global Implantable Drug Delivery Devices Market: End-user Segment Analysis

• Oncology
• Contraception
• Cardiovascular
• Ophthalmology
• Inflammatory Conditions
• Diabetes
• Others

Global Implantable Drug Delivery Devices Market: Regional Segment Analysis

• North America
  • U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com